Table 4

Univariate and multivariate logistic regression analyses with poststratification weights applied

Univariate ORP valueMultivariate ORP value
Age1.015 (1.001 to 1.029)0.0361.006 (0.986 to 1.026)0.584
Male gender4.975 (3.332 to 7.426)<0.00019.951 (6.025 to 16.435)<0.0001
COVID-19 duration1.000 (0.991 to 1.009)0.962
Had COVID-19 during the first wave1.537 (0.944 to 2.502)0.0841.126 (0.523 to 2.426)0.762
Had cough1.397 (1.003 to 1.945)0.0481.090 (0.677 to 1.755)0.723
Had dyspnoea1.786 (1.272 to 2.506)0.0011.627 (0.922 to 2.870)0.093
Had myalgia0.944 (0.665 to 1.341)0.749
Had arthralgia0.822 (0.587 to 1.151)0.254
Had anosmia0.842 (0.593 to 1.195)0.336
Intensity of COVID-19 treatment setting1.727 (1.344 to 2.218)<0.00011.548 (0.937 to 2.58)0.088
Treated with analgesics/NSAIDs1.182 (0.828 to 1.686)0.3570.983 (0.592 to 1.631)0.947
Treated with LMWH2.180 (1.472 to 3.229)<0.00011.897 (0.944 to 3.812)0.072
Treated with HCQ1.969 (1.088 to 3.562)0.0251.313 (0.464 to 3.713)0.607
Treated with supplemental oxygen2.531 (1.514 to 4.229)<0.00010.482 (0.181 to 1.283)0.144
Pre-existent arthritis0.664 (0.273 to 1.614)0.366
Pre-existent anxiety1.314 (0.858 to 2.013)
Pre-existent depression1.255 (0.642 to 2.452)0.507
Pre-existent high blood pressure3.061 (1.964 to 4.770)<0.00011.511 (0.781 to 2.925)0.220
Pre-existent diabetes0.849 (0.219 to 3.290)0.813
Pre-existent pulmonary disease1.164 (0.634 to 1.164)0.624
Pre-existent obesity41.192 (18.003 to 98.879)<0.000182.823 (32.192 to 213.084)<0.0001
  • P values <0.05 are highlighted in bold.

  • HCQ, hydroxychloroquine; LMWH, low-molecular-weight heparin; NSAIDs, Nonsteroidal anti-inflammatory drugs.